false
OasisLMS
Login
Catalog
SHM Converge Scientific Abstract ePoster Gallery
Paraneoplastic Dermatomyositis Secondary to Gastro ...
Paraneoplastic Dermatomyositis Secondary to Gastrointestinal Stromal Tumor
Back to course
Pdf Summary
This case describes an 84-year-old man with hyperlipidemia who presented with six weeks of erythematous rash, proximal muscle weakness, and later dysphagia. His exam showed classic dermatomyositis findings, including a shawl-like rash, periorbital edema, cutaneous ulceration, Gottron’s papules, and periungual erythema, with symmetric proximal weakness in both upper and lower extremities. Laboratory workup showed markedly elevated creatine kinase, elevated ESR, and a high ANA titer, while anti-Jo-1, mitochondrial, and smooth muscle antibodies were negative.<br /><br />He was initially treated as an outpatient with steroid taper after skin biopsy confirmed dermatomyositis, but his weakness worsened and dysphagia developed, prompting hospital admission. In the hospital, he received pulse-dose steroids without improvement, followed by high-dose oral steroids. Because of persistent disease, IVIG was started on hospital day 7 and seemed to improve symptoms, leading to methotrexate maintenance therapy. CT and PET imaging then revealed a gastric mass, and biopsy confirmed a spindle cell gastrointestinal stromal tumor (GIST). Neoadjuvant imatinib was started on day 16.<br /><br />Despite treatment, the patient deteriorated on day 29 with septic shock from aspiration pneumonia, requiring intubation and vasopressors. He was unable to be weaned from the ventilator and transitioned to comfort care, dying on hospital day 47.<br /><br />The case highlights several important points: updated idiopathic inflammatory myopathy criteria may have allowed earlier dermatomyositis diagnosis; cutaneous ulceration may indicate a severe, treatment-resistant course; and delays in IVIG may worsen dysphagia and aspiration risk. It also emphasizes the need for malignancy screening in dermatomyositis, including rare paraneoplastic causes such as GIST, which may respond well to imatinib if localized.
Asset Subtitle
Daniel M. Camp
Meta Tag
Author List
Daniel M. Camp, Frank Aguilar
Category
Clinical Vignettes
Concept
Dermatomyositis
Concept
Paraneoplastic Syndrome
Concept
Malignancy Screening
Concept
Clinical Feature
Concept
Diagnostic Approach
Distinguished
Non-Finalist
Presenter Organization
Northwestern University
Presenting Author
Daniel M. Camp
Track
Adult
Keywords
dermatomyositis
proximal muscle weakness
dysphagia
cutaneous ulceration
Gottron’s papules
elevated creatine kinase
intravenous immunoglobulin
gastrointestinal stromal tumor
paraneoplastic syndrome
imatinib
Dermatomyositis
Paraneoplastic Syndrome
Malignancy Screening
Clinical Feature
Diagnostic Approach
×
Please select your language
1
English